The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...

PathAI, a global leader in AI-powered digital pathology solutions, and A.C.Camargo Cancer Center, a national benchmark in oncological treatment, education, and research, are joining forces ...

PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...

ArteraAI Breast is designed to stratify breast cancer patients into high- and low-risk groups to guide treatment decisions.

The FDA has cleared ArteraAI Breast, the first digital pathology-based risk stratification tool for breast cancer. The AI software analyzes tumor tissue images and clinical data to categorize ...

Dicom Systems, a leader in enterprise imaging workflow orchestration and interoperability, announced today that it will partner with Moffitt Cancer Center to support and scale its digital pathology ...

In a recent study published in the journal Nature, researchers developed and evaluated the Providence Gigapixel Pathology Model (Prov-GigaPath), a whole-slide pathology foundation model, to achieve ...

Researchers at University Hospital Cologne have developed SPARK, an AI-based pathology framework that autonomously generates and refines biological hypotheses from tissue images. Tested on over 5,400 ...

The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today’s artificial intelligence (AI) techniques now go far beyond mere automation: they make it possible ...

A study warns that millions of people with cancer could die undiagnosed due to failures in healthcare systems.